Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8095259 | 0.88 | CYP2A6 (0.43) | CYP19A1 | |
| SCHEMBL5332634 | 0.87 | HTR2A (0.41) | CYP19A1KCNH2SIGMAR1 | |
| SCHEMBL7426041 | 0.86 | CFTR (0.41) | CYP19A1KCNH2 | |
| SCHEMBL11712943 | 0.83 | CYP19A1 (0.39) | CYP19A1KCNH2ACP3SIGMAR1 | |
| SCHEMBL8083442 | 0.83 | HRH1 (0.40) | CYP19A1 | |
| SCHEMBL6468709 | 0.83 | HTR2A (0.47) | CYP19A1KCNH2SIGMAR1 | |
| SCHEMBL1538332 | 0.82 | CYP19A1 (0.54) | CYP19A1KCNH2ACP3SIGMAR1 | |
| SCHEMBL1170712 | 0.81 | CYP19A1 (0.40) | CYP19A1KCNH2ACP3SIGMAR1 | |
| SCHEMBL7430622 | 0.80 | CYP19A1 (0.46) | CYP19A1KCNH2SIGMAR1FDFT1 | |
| SCHEMBL6571451 | 0.79 | TSHR (0.39) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1404325-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2002096420-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2002-12-05 | — | — | WO | disclosed |
| EP-0957913-A4 | N-LINKED SULFONAMIDES OF HETEROCYCLIC THIOESTERS | GUILFORD PHARM INC (US) | 2002-05-02 | — | — | EP | disclosed |
| CN-1336930-A | Bridged heterocyclic derivatives | GPINIL HOLDING CORP (US) | 2002-02-20 | — | — | CN | disclosed |
| EP-1127049-A1 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL Holdings, Inc. (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1085854-A1 | N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES | GPI NIL Holdings, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| US-6121273-A | ISOMERASE INHIBITORS EFFECTIVE AGAINST NEUROLOGICAL DISORDERS, I.E. PARKINSON'S DISEASE, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS; SIDE EFFECT REDUCTION | GPI NIL HOLDINGS, INC (US) | 2000-09-19 | — | — | US | disclosed |
| EP-1011650-A1 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | Amgen Inc., (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-0859614-A4 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARM INC (US) | 2000-04-26 | — | — | EP | disclosed |
| WO-2000016603-A2 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL HOLDINGS, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| US-6004993-A | TREATMENT OF ALOPECIA IN ANIMALS | GPI NIL HOLDINGS, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999062489-A1 | N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES | GPI NIL HOLDINGS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0957913-A1 | N-LINKED SULFONAMIDES OF HETEROCYCLIC THIOESTERS | GUILFORD PHARMACEUTICALS INC. (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1999014998-A2 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | AMGEN INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| EP-0859614-A1 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1998029116-A1 | N-LINKED SULFONAMIDES OF HETEROCYCLIC THIOESTERS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1997016190-A1 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1997-05-09 | — | — | WO | disclosed |